DUBLIN, Nov. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering.
Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring.
This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Preimplantation Genetic Diagnosis Market Overview
Chapter 4 Global Preimplantation Genetic Diagnosis Market, by Test Type
Chapter 5 Preimplantation Genetic Diagnosis Market, by Geography
Chapter 6 Recommendations
Chapter 7 Company Profiles
- Genea Ltd.
- Genesis Genetics
- Illumina, Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Natera, Inc.
- PerkinElmer, Inc.
- Quest Diagnostics, Inc.
- Reproductive Genetics Institute
- Reprogenetics LLC
For more information visit http://www.researchandmarkets.com/research/hf83mq/preimplantation
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets